4883 — Modalis Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Modalis Therapeutics, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5,421 | 4,936 | 2,933 | 1,883 | 3,575 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,449 | 5,067 | 3,061 | 1,956 | 3,617 |
| Net Property, Plant And Equipment | 49.8 | 224 | — | — | — |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,277 | 6,069 | 3,130 | 2,026 | 3,692 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 58.3 | 181 | 142 | 198 | 117 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 70.2 | 520 | 189 | 646 | 143 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 6,207 | 5,549 | 2,941 | 1,380 | 3,548 |
| Total Liabilities & Shareholders' Equity | 6,277 | 6,069 | 3,130 | 2,026 | 3,692 |
| Total Common Shares Outstanding |